FDA Alerts U.S. Residents To British Recall Of Counterfeit Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
U.S. residents may have received the counterfeit statin if they purchased drugs online, from storefront operations that supply unapproved drugs, or through state-run drug importation programs, FDA warns.
You may also be interested in...
Pfizer Expands Color-Shifting Labels Beyond Viagra To Celebrex, Lipitor
Pfizer is expanding its use of color-shifting labels beyond Viagra to five other products as part of its anti-counterfeiting efforts.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.
CinFina Pushes Early Work In Obesity In Hopes Of A Deal
Emerging Company Profile: CinFina is advancing two novel mechanisms of action in obesity as monotherapies and in combination with GLP-1s.